We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+30%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.29B
AUM Growth
+$370M
Cap. Flow
+$32.1M
Cap. Flow %
2.48%
Top 10 Hldgs %
19.69%
Holding
198
New
29
Increased
74
Reduced
24
Closed
25

Top Buys

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$20.7M
2
AVTR icon
Avantor
AVTR
+$14.9M
3
TGTX icon
TG Therapeutics
TGTX
+$13.5M
4
CELL
PhenomeX Inc. Common Stock
CELL
+$11.4M
5
TXG icon
10x Genomics
TXG
+$10.3M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$20.9M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$17.8M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$10.4M
4
PEN icon
Penumbra
PEN
+$10.1M
5
TWST icon
Twist Bioscience
TWST
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.02%
2 Technology 12.16%
3 Consumer Discretionary 8.78%
4 Industrials 6.66%
5 Financials 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLAR icon
101
Clarus
CLAR
$143M
$3.25M 0.25%
210,707
+86,054
+69% +$1.31M
NVDA icon
102
NVIDIA
NVDA
$5.42T
$3.16M 0.24%
242,200
+4,040
+2% +$54.1K
EVBG
103
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2.94M 0.23%
19,725
+7,095
+56% +$907K
REAL icon
104
The RealReal
REAL
$1.5B
$2.91M 0.22%
+148,927
New +$2.3M
MCHP icon
105
Microchip Technology
MCHP
$46B
$2.69M 0.21%
38,962
– –
ADI icon
106
Analog Devices
ADI
$190B
$2.58M 0.2%
17,441
+479
+3% +$63.5K
XYZ
107
Block Inc
XYZ
$47.5B
$2.47M 0.19%
11,336
+336
+3% +$65.5K
VERX icon
108
Vertex
VERX
$1.94B
$2.39M 0.18%
68,537
+460
+0.7% +$12.5K
KSU
109
DELISTED
Kansas City Southern
KSU
$2.38M 0.18%
11,670
-56
-0.5% -$10.5K
FRPT icon
110
Freshpet
FRPT
$3.22B
$2.22M 0.17%
15,627
-20,184
-56% -$2.61M
ROKU icon
111
Roku
ROKU
$22.7B
$2.19M 0.17%
6,587
– –
SNPS icon
112
Synopsys
SNPS
$79.7B
$2.11M 0.16%
8,146
– –
BAH icon
113
Booz Allen Hamilton
BAH
$9.15B
$2.08M 0.16%
23,910
– –
PRU icon
114
Prudential Financial
PRU
$41.8B
$1.95M 0.15%
+25,000
New +$1.81M
PRMW
115
DELISTED
Primo Water Corporation
PRMW
$1.92M 0.15%
122,659
+895
+0.7% +$13.2K
VITL icon
116
Vital Farms
VITL
$525M
$1.86M 0.14%
73,476
-12,114
-14% -$383K
EVA
117
DELISTED
Enviva Inc.
EVA
$1.65M 0.13%
36,324
– –
SPLK
118
DELISTED
Splunk Inc
SPLK
$1.59M 0.12%
9,354
+1,199
+15% +$229K
KLAC icon
119
KLA
KLAC
$259B
$1.45M 0.11%
55,890
+4,200
+8% +$97.9K
MRTN icon
120
Marten Transport
MRTN
$1.22B
$1.37M 0.11%
+79,498
New +$1.36M
IWM icon
121
iShares Russell 2000 ETF
IWM
$81.9B
$1.34M 0.1%
6,822
+3,202
+88% +$560K
BALL icon
122
Ball Corp
BALL
$16.8B
$1.31M 0.1%
14,052
-128
-0.9% -$11.8K
CDNS icon
123
Cadence Design Systems
CDNS
$93.4B
$1.29M 0.1%
9,492
+616
+7% +$72.3K
BURL icon
124
Burlington
BURL
$23.2B
$1.29M 0.1%
4,930
+3,017
+158% +$672K
FIVE icon
125
Five Below
FIVE
$13.5B
$1.23M 0.1%
7,047
-15,580
-69% -$2.31M
3 4
5
6 7

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Nicholas Investment Partners held 198 positions worth $1.29B, up 40% from $925M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Investment Partners's Q4 2020 filing shows 29 new, 74 increased, 24 reduced and 25 closed positions. Its largest new stake was Arena Pharmaceuticals Inc: 276,633 shares worth $21.3M. The largest sale was Immunomedics Inc, an estimated $20.9M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Nicholas Investment Partners's largest Q4 2020 buy was Arena Pharmaceuticals Inc: 276,633 shares worth $21.3M.
  • Nicholas Investment Partners added most to TG Therapeutics in Q4 2020, an estimated $13.5M increase.
  • Nicholas Investment Partners's biggest Q4 2020 reduction was Twist Bioscience, cutting an estimated $10.1M.
  • Nicholas Investment Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.9M.
  • Nicholas Investment Partners's ten largest holdings make up 20% of its $1.29B portfolio in Q4 2020.
  • Nicholas Investment Partners opened 29 new positions and closed 25 in Q4 2020.
  • Nicholas Investment Partners's portfolio value rose 40% quarter-over-quarter to $1.29B.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.